Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

NCT: NCT04790344 · ACTIVE_NOT_RECRUITING

NCT IDNCT04790344
StatusACTIVE_NOT_RECRUITING
Start Date2021-03-20
Completion2026-06

Brief Summary

The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.

Frequently Asked Questions

What is LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.?

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. is a clinical trial registered under NCT04790344. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04790344?

The current status of NCT04790344 (LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.) is: ACTIVE_NOT_RECRUITING.

When did LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. start?

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. started on 2021-03-20.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.